News Release

Geisinger to study genetic causes of cerebral palsy

Research supported by $3.3 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health

Grant and Award Announcement

Geisinger Health System

DANVILLE, Pa. – Andres Moreno De Luca, M.D., M.B.A, assistant professor and neuroradiologist at Geisinger’s Autism & Developmental Medicine Institute, has been awarded $3.3 million from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health to study genetic variants that cause cerebral palsy (CP).

Cerebral palsy is a developmental brain disorder that impacts early motor development, balance and posture. It affects 1 in 500 people and is the most common motor disability in childhood, according to the Centers for Disease Control and Prevention. Birth asphyxia—a lack of oxygen to the brain before, during, or just after birth—was considered the most frequent cause of CP for many years, but multiple studies have shown that it accounts for less than 10 percent of all cases.

A growing body of evidence suggests that a large proportion of CP cases are caused by rare variants in DNA, as has been found in other similar brain disorders. Dr. Moreno De Luca’s study will analyze DNA sequence data from Geisinger’s MyCode® Community Health Initiative paired with electronic health data, as well as DNA sequence data from GeneDx (Sema4), a leader in genomic testing and analysis for rare disorders, to identify the individual genes and regions of the genome responsible for CP.

“We anticipate that this study will provide evidence to support the inclusion of genetic testing in routine clinical care for individuals with cerebral palsy,” Dr. Moreno De Luca said. “This project could also foster future research into molecular mechanisms of disease, helping to develop targeted therapies for specific genomic variants.”

Dr. Moreno De Luca’s team will also analyze MRI studies of a subgroup of participants, allowing the team to identify shared neuroimaging features related to specific genes, gene families and molecular pathways.

About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger Commonwealth School of Medicine. With nearly 24,000 employees and more than 1,700 employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at or connect with us on Facebook, Instagram, LinkedIn and Twitter.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.